Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.

D'AVOLIO, ANTONIO;BONORA, Stefano;
2011

66
885
889
http://dx.doi.org/10.1093/jac/dkq546
Adult, Anticholesteremic Agents; administration /&/ dosage/adverse effects/pharmacokinetics, Antiviral Agents; administration /&/ dosage/adverse effects/pharmacokinetics, Azetidines; administration /&/ dosage/adverse effects/pharmacokinetics, Cross-Over Studies, Drug Therapy; Combination; adverse effects/methods, Female, Human Experimentation, Humans, Male, Middle Aged, Prospective Studies, Pyrrolidinones; administration /&/ dosage/adverse effects/pharmacokinetics
A. Jackson;A. D'Avolio;V. Watson;S. Bonora;D. Back;J. Taylor;K. Armenis;B. Gazzard;G. Moyle;M. Boffito
File in questo prodotto:
File Dimensione Formato  
dkq546.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 197.59 kB
Formato Adobe PDF
197.59 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/98489
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact